Benedict MD - EnVVeno Medical Chief States
| NVNO Stock | USD 4.96 0.04 0.80% |
Insider
Benedict MD is Chief States of enVVeno Medical Corp
| Age | 67 |
| Address | 70 Doppler, Irvine, CA, United States, 92618 |
| Phone | 949 261 2900 |
| Web | https://www.envveno.com |
EnVVeno Medical Management Efficiency
The company has return on total asset (ROA) of (0.3494) % which means that it has lost $0.3494 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5538) %, meaning that it created substantial loss on money invested by shareholders. EnVVeno Medical's management efficiency ratios could be used to measure how well EnVVeno Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 15th of May 2024, Return On Tangible Assets is likely to drop to -0.51. In addition to that, Return On Capital Employed is likely to grow to -0.51. At this time, EnVVeno Medical's Total Assets are very stable compared to the past year. As of the 15th of May 2024, Non Current Assets Total is likely to grow to about 1.8 M, while Non Currrent Assets Other are likely to drop about 29.4 K.Similar Executives
| Showing other executives | INSIDER Age | ||
| Ehab Esmail | Orthofix Medical | 52 | |
| Richard Ginn | Tenon Medical | 58 | |
| Ed Joyce | Axogen Inc | N/A | |
| Derrick Sung | PulmonxCorp | 51 | |
| William MBA | STRATA Skin Sciences | 58 | |
| John Treace | Treace Medical Concepts | 52 | |
| Ilya Goldshleger | Rxsight | 49 | |
| Robert MBA | Talis Biomedical Corp | 52 | |
| Robert Moccia | STRATA Skin Sciences | 65 | |
| Michael Hutchinson | LivaNova PLC | 53 | |
| Mark Quick | Orthofix Medical | N/A | |
| Eric Weinberg | Rxsight | 63 | |
| Rustem Ismagilov | Talis Biomedical Corp | 50 | |
| HuiLan Wu | Ainos Inc | 63 | |
| Marco Dolci | LivaNova PLC | 62 | |
| Fuad Ahmad | IRIDEX | 54 | |
| BA Chemistry | Orthofix Medical | 63 | |
| Christopher Lesovitz | STRATA Skin Sciences | 42 | |
| Darrell Rigel | STRATA Skin Sciences | 73 | |
| Mark CPA | Treace Medical Concepts | 54 | |
| Leigh Salvo | IRIDEX | N/A | |
Management Performance
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.35 |
enVVeno Medical Corp Leadership Team
Elected by the shareholders, the EnVVeno Medical's board of directors comprises two types of representatives: EnVVeno Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EnVVeno. The board's role is to monitor EnVVeno Medical's management team and ensure that shareholders' interests are well served. EnVVeno Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EnVVeno Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Cormack, Chief Officer | ||
| Craig Glynn, Treasurer CFO | ||
| Benedict MD, Chief States | ||
| Robert Berman, CEO Director | ||
| Marc MD, Senior Officer | ||
| Hamed Alavi, Senior Officer | ||
| Warren Hancock, Cofounder |
EnVVeno Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EnVVeno Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 22.91 M | ||||
| Shares Outstanding | 13.32 M | ||||
| Shares Owned By Insiders | 0.38 % | ||||
| Shares Owned By Institutions | 33.02 % | ||||
| Number Of Shares Shorted | 903.33 K | ||||
| Price To Book | 1.44 X | ||||
| EBITDA | (24.69 M) | ||||
| Net Income | (23.52 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EnVVeno Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EnVVeno Medical's short interest history, or implied volatility extrapolated from EnVVeno Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for EnVVeno Stock analysis
When running EnVVeno Medical's price analysis, check to measure EnVVeno Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EnVVeno Medical is operating at the current time. Most of EnVVeno Medical's value examination focuses on studying past and present price action to predict the probability of EnVVeno Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EnVVeno Medical's price. Additionally, you may evaluate how the addition of EnVVeno Medical to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is EnVVeno Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Return On Assets (0.35) | Return On Equity (0.55) |
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.